Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1

Journal of Medical Microbiology

Volumn 54, Issue 10, 2005, Pages 997-998

  Taneja, Neelam ^a   Lyngdoh, Valarie W ^a   Sharma, Meera ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; GENTAMICIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHILD; DRUG CHOICE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SEROTYPE; SHIGELLA DYSENTERIAE; SHIGELLA DYSENTERIAE SEROTYPE 1; SHIGELLOSIS;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; SEROTYPING; SHIGELLA DYSENTERIAE;

EID: 25844512607     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45993-0     Document Type: Article

References (21)

1. Bauer, A. W., Kirby, W. M., Sherries, J. C. & Turck, M. (1995). Antibiotic susceptibility testing by a single method. Am J Clin Pathol 45, 493-496.
2. Bennish, M. L., Harris, J. R., Wojtyniak, B. J. & Struelens, M. (1990). Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis 161, 500-506.
3. Bhimma, R., Rollins, N. C., Coovadia, H. M. & Adhikari, M. (1997). Post-dysenteric hemolytic uraemic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol 11, 560-564.
4. Bhuyan, V. N., Srivastava, R. N. & Choudhry, V. P. (1985). Pathology of acute renal failure and haemolytic uraemic syndrome in acute dysentery in children. Indian J Med Res 81, 402.
5. Butler, T., Islam, M. R., Azad, M. A. & Jones, P. K. (1987). Risk factors for development of haemolytic uraemic syndrome during shigellosis. J Pediatr 110, 894-897.
6. Karmali, M. A., Steele, B. T., Petric, M. & Lim, C. (1983). Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet i, 619-620.
7. Koster, F. T., Levin, J., Walker, L., Tung, K. S., Gilman, R. H., Rahaman, M. M., Majid, M. A., Islam, S. & Williams, R. C., Jr (1978). Hemolytic-uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N Engl J Med 298, 927-933.
8. Koster, F. T., Boonpucknavig, V., Sujaho, S., Gilman, R. H. & Rahaman, M. M. (1984). Renal histopathology in haemolytic uremic syndrome following shigellosis. Clin Nephrol 21, 126.
9. Legros, D., Paquet, C., Dorlencourt, F. & Saoult, E. (1999). Risk factors for death in hospitalised dysentery patients in Rwanda. Trop Med Int Health 4, 428-432.
10. Lopez, E. L., Diaz, M., Grinstein, S. & 10 other authors (1989). Haemolytic uraemic syndrome and diarrhoea in Argentine children: the role of Shiga-like toxins. J Infect Dis 160, 469-475.
11. Nathoo, K. J., Sanders, J. A., Siziya, S. & Mucheche, C. (1995). Haemolytic uraemic syndrome following Shigella dysenteriae type 1 outbreak in Zimbabwe: a clinical experience. Cent Afr J Med 41, 267-274.
12. Nathoo, K. J., Porteous, J. E., Siziya, S., Wellington, M. & Mason, E. (1998). Predictors of mortality in children hospitalised with dysentery in Harare, Zimbabwe. Cent Afr J Med 44, 272-276.
13. NCCLS (2000). Performance Standards for Antimicrobial Susceptibility Testing; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard, 5th edn. Publication M7-A5, vol. 20, no. 2. Wayne, PA: National Committee for Clinical Laboratory Standards.
14. Oneko, M., Nyathi, M. N. & Doehring, E. (2001). Post-dysenteric hemolytic uremic syndrome in Bulawayo, Zimbabwe. Pediatr Nephrol 16, 1142-1145.
15. Raghupathy, P., Date, A., Shastry, J. C., Sundarsanam, A. & Jadhav, M. (1978). Haemolytic-uraemic syndrome complicating shigella dysentery in south Indian Children. BMJ 1, 1518-1521.
16. Remuzzi, G. & Ruggenenti, P. (1995). The haemolytic uraemic syndrome. Kidney Int 48, 2-19.
17. Rollins, N. C., Wittenberg, D. F., Coovadia, H. M., Pillay, D. G., Karas, A. J. & Sturm, A. W. (1995). Epidemic Shigella dysenteriae type 1 in Natal. J Trop Pediatr 41, 281-284.
18. Safdar, N., Said, A., Gangnon, R. E & Maki, D. G. (2002). Risk of hemolytic uraemic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis. JAMA 288, 996-1001.
19. Scotland, S. M., Rowe, B., Smith, H. R., Willshaw, G. A. & Gross, R. J. (1988). Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol 25, 237-243.
20. Siegler, R. L. (1995). The hemolytic uraemic syndrome. Pediatr Clin North Am 42, 1505-1529.
21. Tarr, P. I., Gordon, C. A. & Chandler, W. L. (2005). Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086.